Eli Lilly (LLY)

• Market cap: $996B
• 1 day: 0.92%
• 5 days: 0.05%
• 1 month: 4.93%
• 3 months: 23.72%
• 6 months: 3.74%
• Year to date: 3.42%
• 1 year: 43.59%
• 5 years: 379.57%
• 10 years: 1,403.11%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Employees: 50,000